What laboratory tests should be ordered to evaluate polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Polycythemia Evaluation

Order a complete blood count (CBC) with hemoglobin/hematocrit, JAK2 V617F mutation testing, and serum erythropoietin level as your initial laboratory workup for polycythemia.

Initial Laboratory Panel

When evaluating polycythemia, the diagnostic approach follows a structured algorithm based on WHO criteria that prioritizes identifying primary versus secondary causes 1, 2:

Major Criteria Tests

  1. Complete Blood Count (CBC)

    • Hemoglobin thresholds: ≥18.5 g/dL in men, ≥16.5 g/dL in women (2008 WHO criteria) 2
    • Hematocrit: Can be used alternatively to hemoglobin for centers preferring this parameter 1
    • Red cell mass measurement: No longer routinely required in modern diagnostic algorithms 3
    • Look for accompanying leukocytosis and thrombocytosis, which strongly suggest polycythemia vera over secondary causes 4
  2. JAK2 Mutation Testing

    • JAK2 V617F (exon 14): Present in >95% of polycythemia vera cases 2, 5
    • JAK2 exon 12 mutations: Test if V617F is negative but clinical suspicion remains high 2, 6
    • This has become a major diagnostic criterion and captures >97% of PV cases when combined with elevated hemoglobin 1

Minor Criteria Tests

  1. Serum Erythropoietin Level
    • Below normal reference range supports polycythemia vera 1, 2
    • Normal or elevated suggests secondary polycythemia 7
    • Now classified as a minor criterion in 2008 WHO revision 2

Algorithmic Approach

If polycythemia is isolated (no leukocytosis/thrombocytosis):

  • Prioritize investigating secondary causes first 7
  • Check oxygen saturation, consider sleep studies for hypoxia
  • Review medications (androgens, SGLT2 inhibitors, erythropoietin-stimulating agents)
  • Consider imaging for erythropoietin-secreting tumors

If polycythemia accompanies leukocytosis or thrombocytosis:

  • Immediately order JAK2 mutation testing and serum erythropoietin 7
  • This pattern strongly suggests primary polycythemia vera

Additional Diagnostic Tests

  1. Bone Marrow Biopsy

    • Shows hypercellularity with panmyelosis (trilineage growth) 2
    • Prominent erythroid, granulocytic, and megakaryocytic proliferation
    • Became a major criterion in 2016 WHO revision, allowing lower hemoglobin thresholds (16.5 g/dL men, 16 g/dL women) 5
    • Required when JAK2 is negative but clinical suspicion remains
  2. Endogenous Erythroid Colony Formation

    • In vitro test showing autonomous red cell growth
    • Minor criterion, rarely used in routine practice 1, 2

Critical Diagnostic Combinations

Diagnosis of polycythemia vera requires 1, 2:

  • Both major criteria + ≥1 minor criterion, OR
  • First major criterion (elevated Hgb/Hct) + ≥2 minor criteria (for JAK2-negative cases)

Important Caveats

  • Iron deficiency confounds hemoglobin interpretation; check iron studies and retest after iron replacement if deficient 1
  • Hypochromic microcytic RBCs in the setting of polycythemia suggest iron deficiency from chronic phlebotomy in undiagnosed PV 4
  • Triple-negative cases (JAK2/CALR/MPL negative): Consider next-generation sequencing panels including ASXL1, EZH2, TET2, IDH1/IDH2, SRSF2 for prognostic information and to exclude false negatives 6
  • High altitude: Many patients may be unnecessarily evaluated for PV if hemoglobin/hematocrit is the sole criterion; look for the distinct CBC pattern of leukocytosis, thrombocytosis, and microcytic RBCs to better select candidates 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.